Kooij Louise Frederika Insider Trades

Insider Trading History

Track insider trading activity for Kooij Louise Frederika. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $519k 24,353 shares
Last Trade
May 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.58M 65,000 shares
$24.26
$21.31
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $1.9M 89,353 shares
Last Trade
May 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.58M 65,000 shares
$24.26
$21.31
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $1.71M 80,015 shares
Last Trade
May 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.58M 65,000 shares
$24.26
$21.31
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $519k 24,353 shares
Last Trade
Jan 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$789k 32,612 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $1.86M 56,965 shares
Last Trade
Jan 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 32,612 shares
$32.56
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $1.21M 56,965 shares
Last Trade
Jan 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$789k 32,612 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $2.39M 73,134 shares
Last Trade
Jan 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.06M 32,612 shares
$32.56
$32.67
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $796k 24,353 shares
Last Trade
Jan 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04M 32,612 shares
$31.80
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $1.56M 73,134 shares
Last Trade
Jan 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$789k 32,612 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $519k 24,353 shares
Last Trade
Jan 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$963k 39,816 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $3.45M 105,746 shares
Last Trade
Jan 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.3M 39,816 shares
$32.56
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $1.37M 64,169 shares
Last Trade
Jan 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$963k 39,816 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $796k 24,353 shares
Last Trade
Jan 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.3M 39,816 shares
$32.62
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $2.25M 105,746 shares
Last Trade
Jan 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$963k 39,816 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $2.1M 64,169 shares
Last Trade
Jan 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.3M 39,816 shares
$32.56
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $3.1M 145,562 shares
Last Trade
Jan 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$832k 34,400 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $4.76M 145,562 shares
Last Trade
Jan 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 34,400 shares
$32.37
$32.67
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $806k 24,662 shares
Last Trade
Jan 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.13M 34,400 shares
$32.78
$32.67
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Accounting Officer
Holding Value $526k 24,662 shares
Last Trade
Jan 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$832k 34,400 shares
$24.19
$21.31
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Accounting Officer
Holding Value $1.92M 58,753 shares
Last Trade
Jan 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.11M 34,400 shares
$32.37
$32.67

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up